Cancer Metabolomics Approaches

Metabolomics cancer research is being used to discover diagnostic cancer biomarkers in the clinic and in a research institute, to a better understand its complex heterogeneous nature, to discover pathways which involved in cancer that could be used for new targets and to monitor metabolic biomarkers during therapeutic intervention. These metabolomics approaches may also provide evidence to personalized cancer treatments by providing useful information to the clinician about the cancer patient’s response to medical interventions. The ultimate aims of most metabolomics cancer studies are to discover cancer-specific diagnostic, prognostic or predictive biomarkers for a patient. Untargeted metabolomics is an important and excellent tool for probing cancer-altered biochemical pathways.



 


    Related Conference of Cancer Metabolomics Approaches

    December 14-14, 2020

    2nd Pathology and Infectious Disease Conference

    Dubai, UAE
    March 28-29, 2021

    11th Glycobiology World Congress

    Vienna, Austria
    April 24-24, 2021

    2nd International Conference on Nucleic Acids

    London, UK
    June 11-12, 2021

    25th Global Congress on Biotechnology

    Berlin, Germany
    September 13-14, 2021

    17th World Congress on Structural Biology

    Prague, Czech Republic
    September 27-28, 2021

    25th European Biotechnology Congress

    Dublin, Ireland

    Cancer Metabolomics Approaches Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in